Dragana Trifunovic

Title: Dragana Trifunovic: Innovator in Targeted Drug Delivery

Introduction

Dragana Trifunovic is a prominent inventor based in Tübingen, Germany. She has made significant contributions to the field of drug delivery systems, particularly in the treatment of retinal diseases. Her innovative approach focuses on enhancing the efficacy of therapeutic agents through targeted delivery mechanisms.

Latest Patents

Trifunovic holds a patent for her invention titled "Targeted liposomal delivery of cGMP analogues." This invention relates to methods and means for targeted drug delivery across the blood-ocular barrier. Specifically, it involves cyclic guanosine-3', 5'-monophosphate analogs as therapeutic agents for treating retinal diseases. The invention utilizes glutathione-based ligands to facilitate specific binding and enhanced internalization by glutathione transporters present on the blood-ocular barrier. These ligands are conjugated to nanocontainers, such as liposomes, which encapsulate the cGMP analogs.

Career Highlights

Trifunovic is currently associated with Mireca Medicines GmbH, where she continues to advance her research and development efforts. Her work is pivotal in the ongoing quest to improve drug delivery systems, particularly for ocular applications.

Collaborations

She collaborates with notable colleagues, including Per Ekström and François Paquet-Durand, who contribute to her research initiatives and help drive innovation in the field.

Conclusion

Dragana Trifunovic is a trailblazer in the realm of targeted drug delivery, with her patent showcasing her commitment to improving treatment options for retinal diseases. Her work at Mireca Medicines GmbH and collaborations with esteemed colleagues further highlight her impact on the field.